Europe Molecular Diagnostics Market Forecast to 2030

Europe Molecular Diagnostics Market Forecast to 2030

Europe Molecular Diagnostics Market Forecast to 2030 – Regional Analysis – by Disease Area (Oncology, Infectious Disease, Genetic Testing, Cardiac Diseases, Immune System Disorders, and Others), Technology (Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next-Generation Sequencing, DNA Microarrays, In-Situ Hybridization, and Others), Product and Services (Assays & Kits, Instruments, and Services & Software), and End User (Hospitals & Clinics, Diagnostic Laboratories, Research & Academic Institutes, and Others)

Send Enquiry
Item ID: TIPRE00026715 Category: Tag:

$2,485 – $3,885

Description

The Europe molecular diagnostics market is expected to grow from US$ 4,592.54 million in 2022 to US$ 11,225.77 million by 2030. It is estimated to grow at a CAGR of 11.8% from 2022 to 2030.

Surging Prevalence of Associated Diseases Fuels Europe Molecular Diagnostics Market

Molecular diagnostics procedures can be employed in the detection of a wide range of conditions such as oncologic diseases, infectious diseases, cardiac diseases, and immune system disorders; they can also be used in genetic testing using genetic material such as DNA and RNA for the diagnosis of different diseases. Cancer is one of the leading causes of death worldwide. The early detection of the disease can help prevent death among the patients. According to the data published by the UK.GOV on November 22, 2021, the infection rate of COVID-19 was ~422.7 per 100,000 population. Thus, the rising prevalence of target diseases fuels the molecular diagnostics market growth.

Europe Molecular Diagnostics Market Overview

The European molecular diagnostics market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The region holds a significant share of the global molecular diagnostics market and is expected to register a robust CAGR during 2022–2030. The market growth in Europe is attributed to growing life science research and an increase in government investment in testing infectious diseases.

Chronic diseases such as chronic obstructive pulmonary disease (COPD), diabetes, cancer, and arthritis can be life-threatening if left untreated. For instance, chronic lymphocytic leukemia (CLL) is the most common type of leukemia in Germany. According to the Deutsches Ärzteblatt, the prevalence of CLL in Germany stands at ~6 cases per 100,000; nearly 850 women and 1,000 men die from CLL every year.

Europe Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Million)

Europe Molecular Diagnostics Market Segmentation

The Europe molecular diagnostics market is segmented into disease area, technology, product and services, end user, and country.

Based on disease area, the Europe molecular diagnostics market is segmented into infectious disease, oncology, genetic testing, cardiac diseases, immune system disorders, and others. The infectious disease segment registered the largest Europe molecular diagnostics market share in 2022.

Based on technology, the Europe molecular diagnostics market is segmented into polymerase chain reaction (PCR), in situ hybridization, isothermal nucleic acid amplification technology (INAAT), DNA sequencing and next-generation sequencing (NGS), DNA microarrays, and others. The polymerase chain reaction (PCR) segment registered the largest Europe molecular diagnostics market share in 2022. The polymerase chain reaction (PCR) is further sub segmented into RT-PCR, qPCR, multiplex PCR, and others.

Based on product and services, the Europe molecular diagnostics market is segmented into assays and kits, instruments, and services and software. The assays and kits segment registered the largest Europe molecular diagnostics market share in 2022.

Based on end users, the Europe molecular diagnostics market is segmented into diagnostic laboratories, hospitals and clinics, research and academic institutes, and others. The diagnostic laboratories segment held the largest Europe molecular diagnostics market share in 2022.

Based on country, the Europe molecular diagnostics market has been categorized into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe molecular diagnostics market in 2022.

Abbott Laboratories, Agilent Technologies Inc, Thermo Fisher Scientific Inc, F. Hoffmann-La Roche Ltd, Qiagen NV, bioMerieux SA, Illumina Inc, Danaher, Siemens Healthineers AG, and Novartis AG are some of the leading companies operating in the Europe molecular diagnostics market.

Summary Info

Industry:

Pricing options:

, ,

Geographical coverage:

Year of Publication:

At 11.8% CAGR, the Europe Molecular Diagnostics Market is Speculated to be Worth US$ 11,225.77 Million by 2030, says the research team

According to the research team’ research, the Europe molecular diagnostics market was valued at US$ 4,592.54 million in 2022 and is expected to reach US$ 11,225.77 million by 2030, registering a CAGR of 11.8% from 2022 to 2030. Development of new products and increase in demand for point-of-care testing and surging prevalence of associated diseases are the critical factors attributed to the Europe molecular diagnostics market expansion.

Molecular diagnostic techniques and platforms are being used in all areas of anatomic and clinical pathologies. DNA or RNA sequences that are associated with disease, including single nucleotide polymorphism, deletions, rearrangements, and insertions, can be detected in molecular diagnostic tests. Molecular diagnosis has undergone further improvements after the emergence of COVID-19. Conventionally, CT scans, hematological tests, and RT-PCR were in use for testing. As COVID-19 cases grew rapidly in 2020, the need for rapid, precise testing platforms surged to overcome the disadvantages of conventional testing. Computed tomography (CT), a cost-intensive procedure that may not be available in all hospitals, fails to detect viral infections and other diseases in asymptomatic patients. RT-PCR, which was widely used, was also time-consuming and expensive, and was unable to detect a low viral load during the early stages of infection. Consequently, researchers developed novel approaches to detect SARS-CoV-2, which were faster and more cost effective. Reverse transcription loop-mediated isothermal amplification (RT-LAMP), microarray-based detection, aptamer-based diagnosis, SHERLOCK, SHERLOCKv2, FET Biosensors, cell-based potentiometric diagnosis, and molecular imprinting technology are a few of the examples of novel molecular diagnostics techniques developed for COVID-19 diagnosis. In the last few years, FDA reports have indicated that advancements in molecular testing, antigen-dependent testing, and serological testing have been approved. Collaborative efforts by scientific communities in different countries to manage the COVID-19 pandemic and reduce the extent of mortality have benefited the overall molecular tools and diagnosis landscape, which is likely to create significant opportunities for the molecular diagnostics market in the future.

On the contrary, limitations associated with molecular testing hurdles the growth of Europe molecular diagnostics market.

Based on disease area, the Europe molecular diagnostics market is segmented into infectious disease, oncology, genetic testing, cardiac diseases, immune system disorders, and others. The infectious disease segment held 42.1% share of Europe molecular diagnostics market in 2022, amassing US$ 1,931.90 million. It is projected to garner US$ 4,788.64 million by 2030 to expand at 12.0% CAGR during 2022–2030.

Based on technology, the Europe molecular diagnostics market is segmented into polymerase chain reaction (PCR), in situ hybridization, isothermal nucleic acid amplification technology (INAAT), DNA sequencing and next-generation sequencing (NGS), DNA microarrays, and others. The polymerase chain reaction (PCR) segment held 47.5% share of Europe molecular diagnostics market in 2022, amassing US$ 2,182.30 million. It is projected to garner US$ 5,497.17 million by 2030 to expand at 12.2% CAGR during 2022–2030. The polymerase chain reaction (PCR) is further sub segmented into RT-PCR, qPCR, multiplex PCR, and others.

Based on product and services, the Europe molecular diagnostics market is segmented into assays and kits, instruments, and services and software. The assays and kits segment held 64.7% share of Europe molecular diagnostics market in 2022, amassing US$ 2,969.82 million. It is projected to garner US$ 7,513.11 million by 2030 to expand at 12.3% CAGR during 2022–2030.

Based on end users, the Europe molecular diagnostics market is segmented into diagnostic laboratories, hospitals and clinics, research and academic institutes, and others. The diagnostic laboratories segment held 39.3% share of Europe molecular diagnostics market in 2022, amassing US$ 1,807.09 million. It is projected to garner US$ 4,538.76 million by 2030 to expand at 12.2% CAGR during 2022–2030.

Based on country, the Europe molecular diagnostics market has been categorized into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Our regional analysis states that Germany captured 25.7% share of Europe molecular diagnostics market in 2022. It was assessed at US$ 1,178.27 million in 2022 and is likely to hit US$ 2,944.39 million by 2030, exhibiting a CAGR of 12.1% during 2022–2030.

Key players operating in the Europe molecular diagnostics market are Abbott Laboratories, Agilent Technologies Inc, Thermo Fisher Scientific Inc, F. Hoffmann-La Roche Ltd, Qiagen NV, bioMerieux SA, Illumina Inc, Danaher, Siemens Healthineers AG, and Novartis AG, among others.

In July 2023, Thermo Fisher launched new software for molecular diagnostics labs. This software helps in streamlining routine diagnostics testing for standardization and rapid time-to-results. It can enhance the potential of a lab to dynamically respond to quickly changing testing environments by connecting workflow steps within a single interface. In Nov 2021, Thermo Fisher Scientific Inc., the world leader in serving science, has innovative proteomics solutions and a series of co-marketing agreements with industry experts, advancing the throughput, comprehensiveness, and quality of proteomics workflows for applications such as single-cell studies and translational research.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe molecular diagnostics market.
o Highlights key business priorities in order to assist companies to realign their business strategies
o The key findings and recommendations highlight crucial progressive industry trends in the Europe molecular diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
o Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the molecular diagnostics market, as well as those hindering it
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

TABLE OF CONTENTS

1. Introduction
1.1 The Research Team Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Molecular Diagnostics Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Europe PEST Analysis
5. Europe Molecular Diagnostics Market – Key Industry Dynamics
5.1 Key Market Drivers:
5.1.1 Development of New Products and Increase in Demand for Point-of-Care Testing
5.1.2 Surging Prevalence of Associated Diseases
5.2 Market Restraints
5.2.1 Limitations Associated with Molecular Testing
5.3 Market Opportunities
5.3.1 Advancements in Molecular Diagnostics Technologies
5.4 Future Trends
5.4.1 Molecular Diagnostics in Personalized Medicine
5.5 Impact Analysis:
6. Molecular Diagnostics Market – Europe Market Analysis
6.1 Europe Molecular Diagnostics Market Revenue (US$ Mn), 2022 – 2030
7. Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 – by Disease Area
7.1 Overview
7.2 Europe Molecular Diagnostics Market Revenue Share, by Disease Area 2022 & 2030 (%)
7.3 Oncology
7.3.1 Overview
7.3.2 Oncology: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Infectious Disease
7.4.1 Overview
7.4.2 Infectious Disease: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Genetic Testing
7.5.1 Overview
7.5.2 Genetic Testing: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Cardiac Diseases
7.6.1 Overview
7.6.2 Cardiac Diseases: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.7 Immune System Disorders
7.7.1 Overview
7.7.2 Immune System Disorders: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8. Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 – by Technology
8.1 Overview
8.2 Europe Molecular Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
8.3 Polymerase Chain Reaction
8.3.1 Overview
8.3.2 PCR: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.3.2.1 RT-PCR
8.3.2.1.1 Overview
8.3.3 RT-PCR: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.3.3.1 qPCR
8.3.3.1.1 Overview
8.3.4 qPCR: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.3.4.1 Multiplex PCR
8.3.4.1.1 Overview
8.3.5 Multiplex PCR: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.3.5.1 Others
8.3.5.1.1 Overview
8.3.6 Others: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Isothermal Nucleic Acid Amplification Technology (INAAT)
8.4.1 Overview
8.4.2 Isothermal Nucleic Acid Amplification Technology (INAAT): Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.5 DNA Sequencing and Next-Generation Sequencing (NGS)
8.5.1 Overview
8.5.2 DNA Sequencing and Next-Generation Sequencing (NGS): Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.6 DNA Microarrays
8.6.1 Overview
8.6.2 DNA Microarrays: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.7 In-Situ Hybridization (ISH)
8.7.1 Overview
8.7.2 In-Situ Hybridization (ISH): Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9. Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 – by Product and Services
9.1 Overview
9.2 Europe Molecular Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
9.3 Assays and Kits
9.3.1 Overview
9.3.2 Assays and Kits: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Instruments
9.4.1 Overview
9.4.2 Instruments: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Services and Software
9.5.1 Overview
9.5.2 Services and Software: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10. Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 – by End User
10.1 Overview
10.2 Europe Molecular Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
10.3 Hospitals and Clinics
10.3.1 Overview
10.3.2 Hospitals and Clinics: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Diagnostics Laboratories
10.4.1 Overview
10.4.2 Diagnostics Laboratories: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.5 Research and Academic Institutes
10.5.1 Overview
10.5.2 Research and Academic Institutes: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11. Europe Molecular Diagnostics Market – Country Analysis
11.1 Europe Molecular Diagnostics Market, Revenue and Forecast to 2030
11.1.1 Overview
11.1.1.1 Europe Molecular Diagnostics Market by Country
11.1.2 Germany
11.1.2.1 Overview
11.1.3 Germany: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.4 Germany: Molecular Diagnostics Market, by Disease Area
11.1.5 Germany: Molecular Diagnostics Market, by Technology
11.1.5.1 Germany: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.1.6 Germany: Molecular Diagnostics Market, by Product and Services
11.1.7 Germany: Molecular Diagnostics Market, by End User
11.1.8 UK
11.1.8.1 Overview
11.1.9 UK : Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.10 UK: Molecular Diagnostics Market, by Disease Area
11.1.11 UK: Molecular Diagnostics Market, by Technology
11.1.11.1 UK: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.1.12 UK: Molecular Diagnostics Market, by Product and Services
11.1.13 UK: Molecular Diagnostics Market, by End User
11.1.14 France
11.1.14.1 Overview
11.1.15 France: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.16 France: Molecular Diagnostics Market, by Disease Area
11.1.17 France: Molecular Diagnostics Market, by Technology
11.1.17.1 France: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.1.18 France: Molecular Diagnostics Market, by Product and Services
11.1.19 France: Molecular Diagnostics Market, by End User
11.1.20 Italy
11.1.20.1 Overview
11.1.21 Italy: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.22 Italy: Molecular Diagnostics Market, by Disease Area
11.1.23 Italy: Molecular Diagnostics Market, by Technology
11.1.23.1 Italy: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.1.24 Italy: Molecular Diagnostics Market, by Product and Services
11.1.25 Italy: Molecular Diagnostics Market, by End User
11.1.26 Spain
11.1.26.1 Overview
11.1.27 Spain: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.28 Spain: Molecular Diagnostics Market, by Disease Area
11.1.29 Spain: Molecular Diagnostics Market, by Technology
11.1.29.1 Spain: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.1.29.1.1 Spain: Molecular Diagnostics Market, by Product and Services
11.1.30 Spain: Molecular Diagnostics Market, by End User
11.1.31 Rest of Europe
11.1.31.1 Overview
11.1.32 Rest of Europe: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.33 Rest of Europe: Molecular Diagnostics Market, by Disease Area
11.1.34 Rest of Europe: Molecular Diagnostics Market, by Technology
11.1.34.1 Rest of Europe: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.1.35 Rest of Europe: Molecular Diagnostics Market, by Product and Services
11.1.36 Rest of Europe: Molecular Diagnostics Market, by End User
12. Europe Molecular Diagnostics Market Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Europe Molecular Diagnostics Market, Key Company Profiles
13.1 Abbott Laboratories
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Agilent Technologies Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Thermo Fisher Scientific Inc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 F. Hoffmann-La Roche Ltd
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Qiagen NV
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 bioMerieux SA
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Illumina Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Danaher
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Siemens Healthineers AG
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Novartis AG
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About Us
14.2 Glossary of Terms

LIST OF TABLES

Table 1. Europe Molecular Diagnostics Market Segmentation
Table 2. Germany: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Disease Area
Table 3. Germany: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology
Table 4. Germany: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 5. Germany: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 6. Germany: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 7. UK: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area
Table 8. UK: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology
Table 9. UK: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 10. UK: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 11. UK: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 12. France: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area
Table 13. France: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology
Table 14. France: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 15. France: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 16. France: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 17. Italy: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area
Table 18. Italy: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology
Table 19. Italy: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 20. Italy: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 21. Italy: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 22. Spain: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area
Table 23. Spain: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology
Table 24. Spain: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 25. Spain: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 26. Spain: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 27. Rest of Europe: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area
Table 28. Rest of Europe: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology
Table 29. Rest of Europe: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 30. Rest of Europe: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 31. Rest of Europe: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 32. Organic Developments Done By Companies
Table 33. Inorganic Developments Done By Companies
Table 34. Glossary of Terms, Molecular Diagnostics Market

LIST OF FIGURES

Figure 1. Europe – PEST Analysis
Figure 2. Europe Molecular Diagnostics Market – Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Europe Molecular Diagnostics Market Revenue (US$ Mn), 2022 – 2030
Figure 5. Europe Molecular Diagnostics Market Revenue Share, by Disease Area 2022 & 2030 (%)
Figure 6. Oncology: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Infectious Disease: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Genetic Testing: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Cardiac Diseases: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Immune System Disorders: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Others: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Europe Molecular Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
Figure 13. PCR: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. RT-PCR: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. qPCR: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Multiplex PCR: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Others: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Isothermal Nucleic Acid Amplification Technology (INAAT): Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. DNA Sequencing and Next-Generation Sequencing (NGS): Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. DNA microarrays: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. In-Situ Hybridization (ISH): Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Others: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Europe Molecular Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
Figure 24. Assays and Kits: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. Instruments: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. Services and Software: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. Europe Molecular Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
Figure 28. Hospitals and Clinics: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29. Ambulatory Surgical Centers: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 30. Research and Academic Institutes: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 31. Others: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 32. Europe Molecular Diagnostics Market, By country, 2022 ($Mn)
Figure 33. Europe Molecular Diagnostics Market, By Key Countries, 2022 And 2030 (%)
Figure 34. Germany: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 35. UK: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 36. France: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 37. Italy: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 38. Spain: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 39. Rest of Europe: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 40. Growth Strategies Done by the Companies in the Market (%)

The List of Companies – Europe Molecular Diagnostics Market

o Abbott Laboratories
o Agilent Technologies Inc
o bioMerieux SA
o Danaher
o F. Hoffmann-La Roche Ltd
o Illumina Inc
o Novartis AG
o Qiagen NV
o Siemens Healthineers AG
o Thermo Fisher Scientific Inc

Reviews

There are no reviews yet.

Be the first to review “Europe Molecular Diagnostics Market Forecast to 2030”